Abstract:Abstract Background Liver cancer is among the most common malignancy worldwide. Hepatocellular carcinoma (HCC), the principal histological subtype of liver cancer, is globally the third most common cause of cancer-related mortality. The high rates of recurrence and metastasis contribute to the poor prognosis of HCC patients. In recent years, increasing evidence has shown that microRNAs (miRNAs) are involved in the tumorigenesis, progression, and prognosis of HCC. Methods To screen for key candidate miRNAs in HCC, three microarray datasets were downloaded from Gene Expression Omnibus (GEO). The sole common differentially expressed miRNA (DEmiR) observed in the above three datasets using a Venn diagram was microRNA-211-5p (miR-211-5p). The expression of miR-211-5p from HCC tissues was measured in several HCC cell lines. Additionally, using Kaplan–Meier plots, the potential prognostic value of miR-211-5p in HCC was analyzed. Cell counting kit-8 (CCK-8) and transwell assays examined the ability of miR-211-5p to induce cell proliferation, migration, and invasion in HCC cultures. The interaction of miR-211-5p and Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) was assessed both theoretically and using a luciferase reporter assay. Finally, the ability of miR-211-5p to modulate tumorigenesis in HCC in vivo was assessed after establishing a xenograft model. Results qRT-PCR demonstrated that the relative expression of miR-211-5p was considerably down-regulated in HCC tissues and cell lines compared with normal tissue. Kaplan–Meier plots indicated that HCC patients with decreased expression of miR-211-5p had poor overall survival. Upregulation of miR-211-5p in vitro consistently suppressed cell proliferation, migration, and invasion. In contrast, enhanced expression of ACSL4 promoted a malignant phenotype in HCC cells. Importantly, we discovered that ACSL4 was a direct downstream target of miR-211-5p in HCC, and that miR-211-5p suppressed the malignant phenotype by inhibition of ACSL4 expression. Furthermore, miR-211-5p overexpression impaired tumorigenesis and growth of HCC in vivo. Conclusions Targeting miR-211-5p and the downstream gene ACSL4 will possibly provide novel insight and represents a promising approach to future therapy of HCC patients.

Genetic switch selectively kills hepatocellular carcinoma cell based on microRNA and tissue-specific promoter

MicroRNA‐122 Suppresses Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma by Directly Targeting Wnt/β‐catenin Pathway

Regulatory MiR‐148a‐ACVR1/BMP Circuit Defines a Cancer Stem Cell‐like Aggressive Subtype of Hepatocellular Carcinoma

MiR-148b Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma by Targeting WNT1/β-catenin Pathway

Cell-Specific Expression of Artificial Micrornas Targeting Essential Genes Exhibit Potent Antitumor Effect on Hepatocellular Carcinoma Cells

MiR-875-5p suppresses Gli1 to alter the hedgehog signaling pathway, which in turn has hepatocellular cancer-related tumor suppressing properties

Cross-regulation Between Micrornas and Key Proteins of Signaling Pathways in Hepatocellular Carcinoma

Alpha-Fetoprotein Promoter-Driven Cre/LoxP-Switched RNA Interference for Hepatocellular Carcinoma Tissue-Specific Target Therapy

MicroRNA-452 Promotes Stem-Like Cells of Hepatocellular Carcinoma by Inhibiting Sox7 Involving Wnt/β-catenin Signaling Pathway

miR-152-3p Modulates hepatic carcinogenesis by targeting cyclin-dependent kinase 8

A miRNA-mediated attenuation of hepatocarcinogenesis in both hepatocytes and Kupffer cells

Protocol for screening potential targets for the treatment of hepatocellular carcinoma based on H22 tumor-bearing mouse model

Therapeutics Based on microRNA: A New Approach for Liver Cancer

MicroRNA-451 Regulates Activating Transcription Factor 2 Expression and Inhibits Liver Cancer Cell Migration.

Tumor-triggered Personalized Microrna Cocktail Therapy for Hepatocellular Carcinoma

Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma

Microrna-134 Inhibits Hcc Cell Growth And Migration Through The Akt/Gsk3 Beta/Snail Signaling Pathway

Tumor-triggered MicroRNA Cocktail Therapy for Hepatocellular Carcinoma

Chimeric RNA-binding protein-based killing switch targeting hepatocellular carcinoma cells

MicroRNA-181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG

MiR-875-5p Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Repressing Astrocyte Elevated Gene-1 (AEG-1) Expression